id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-2881-0012,FDA,FDA-2015-N-2881,"Final Transcripts from FDA CDRH re: Public Meeting November 12, 2015",Other,Transcript(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-28T17:48:17Z,,0,0,0900006481dd4b57
FDA-2015-N-2881-0002,FDA,FDA-2015-N-2881,"Standards-Based Approach to Analytical Performance Evaluation of
Next Generation Sequencing in Vitro Diagnostic Tests; Public Workshop;
Reopening of Comment Period",Notice,Extension of Comment Period,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,2015-12-25T04:59:59Z,2015-12-25T22:00:33Z,2015-30937,0,0,0900006481d92514
FDA-2015-N-2881-0001,FDA,FDA-2015-N-2881,"Standards-Based Approach to Analytical Performance Evaluation of
Next Generation Sequencing in Vitro Diagnostic Tests; Public Workshop;
Request for Comments",Notice,Meeting,2015-09-09T04:00:00Z,2015,9,2015-09-09T04:00:00Z,2015-11-26T04:59:59Z,2015-11-25T22:00:45Z,2015-22676,0,0,0900006481c61c1a